Rock Springs Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Rock Springs Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-568,252	Closed	-$4.6M	–	150
2021 Q3	$4.6M	Hold	568,252	–	–	0.1%	130
2021 Q2	$5.59M	Hold	568,252	–	–	0.11%	135
2021 Q1	$5.01M	Buy	568,252 +700	+0.1%	+$7.68K	0.11%	132
2020 Q4	$5.81M	Hold	567,552	–	–	0.12%	133
2020 Q3	$5.13M	Hold	567,552	–	–	0.13%	129
2020 Q2	$4.05M	Buy	567,552 +67,552	+14%	+$717K	0.11%	130
2020 Q1	$4.75M	Hold	500,000	–	–	0.2%	103
2019 Q4	$6.58M	Buy	+500,000	New	+$6.1M	0.21%	99

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rock Springs Capital Management's GRTX Position: Q4 2021 in Review

Rock Springs Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 568,252 shares — an estimated $4.6M sold.

Rock Springs Capital Management first reported a position in GRTX in Q4 2019 and held it in 8 quarters. The position peaked at $6.58M in Q4 2019. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

Rock Springs Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Rock Springs Capital Management sold 568,252 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $4.6M.
Rock Springs Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Rock Springs Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $6.58M in Q4 2019.
44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Rock Springs Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.